CD BioSciences Launches Cell Death Solutions for Life Science Researchers

CD BioSciences recently announced the launch of a comprehensive panel of research solutions covering all aspects of cell death study.

Amerigo Scientific Launches New Polyclonal Antibody to Human Blood Coagulation Factor XIII

Amerigo Scientific recently announced the launch of its new polyclonal antibody to human blood coagulation factor XIII for the detection of blood coagulation factor XIII.

STEMart Launches Biological Indicator Sterility Testing Service for Medical Devices

STEMart has recently introduced Biological Indicator Sterility Testing services for the industry of medical devices.

Creative Diagnostics Introduces Fluorometric Neuraminidase Assay Service for High-throughput Discovery

Creative Diagnostics recently introduced Fluorometric Neuraminidase Assay services to the global research community.

CCS Selects ZeOmega’s Care Management Solution to Improve Outcomes for Diabetes Patients While Reducing Costs

Integration Identifies Members’ Needs, Helps Guide Home Healthcare Delivery

A Robust Telomere Aging Clocks Platform Helps Conduct Lab-Grade Telomere Length Analysis

A robust telomere aging clocks system combined with RF, qPCR, STELA, and TESLA techniques is newly reconfigured to conduct specialized lab-grade telomere length analysis and offer comprehensive pictures of biological aging.

CyncHealth to Showcase Successful Partnership at Lyniate Customer Conference Leading HIE Partners with Lyniate on Interoperability Suite to Power Regional Data Exchange

Form Bio Doubles Down on Growth Strategy; Hires Top Industry Exec to Fuel Sales and Customer Acquisition Mark Swendsen Appointed Chief Revenue Officer, Further Strengthening Veteran Leadership Team

Form Bio is a new, cutting-edge research and discovery platform for individuals and enterprises in life sciences. With the most accessible, comprehensive and collaborative platform in the field, Form Bio empowers scientists to efficiently and effectively harness the proliferation of data and computing power that has transformed the science of discovery. Form offers end-to-end integration of the discovery process with intuitive and easy-to-use software applications, combined with an open and adaptable collaborative environment. Form Bio was developed within Colossal Biosciences and co-founded by Ben Lamm, Andrew Busey, and Kent Wakeford. For more information on Form Bio, please visit www.formbio.com

Samsung Biologics obtains three global ISO certifications

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today it has successfully renewed its ISO 27001 certification (Information Security Management System) and obtained ISO 27017 certification (Information Security in cloud services) and ISO 37001 certification (Anti-bribery management systems).

CDMO Services Released by Alfa Chemistry Offer New Possibilities for Pharmaceutical Development & Manufacturing

Known for its competence, responsibility, and innovative capability in chemical supply, Alfa Chemistry recently unveiled its new role as a CDMO service provider for pharmaceutical companies worldwide.

Celegence unveils next level efficiencies for eCTD compliance with new functionality added to Dossplorer™

New functionality added to advanced dossier management solution to bring greater efficiencies to eCTD compliance

PUROLITE'S NEW STATE-OF-THE-ART FACILITY MARKS INNOVATIVE BIOPROCESSING MANUFACTURING EXPANSION

A ribbon-cutting ceremony was held on Thursday, October 13 to celebrate the achievement of Purolite, an Ecolab company’s increased bioprocessing resin production to meet the growing demand for biopharmaceutical products globally.

Creative Peptides Rolls Out Ready-to-Ship Fmoc-Tyr(HP03Bzl)-OH Product from Small Quantity to Large Scale

Creative Peptides announces to provide ready-to-ship Fmoc-Tyr(HP03Bzl)-OH products with 90% and 95% purities, which can be ordered in small amounts or large scale according to client demand.

BioIVT Opens New Blood Donor Center in Glasgow, Scotland

Located in the West of Scotland Science Park, this new facility will produce fresh leukopaks for cell and gene therapy research in the UK and Europe.

Dr. Brett King Joins BiologicsMD as Senior Scientific Advisor and Member of the Scientific Advisory Board

BiologicsMD, a preclinical therapeutic development company focused on highly-targeted treatments for hair loss and bone disorders, announced today the appointment of Brett King, MD, PhD, Associate Professor of Dermatology at Yale Medical School, as a Senior Scientific Advisor to the company’s management team and Board of Directors.

Quotient Sciences Completes Major Expansion of Drug Substance Manufacturing Facility

Quotient Sciences, the drug development and manufacturing accelerator, has completed the expansion of its drug substance manufacturing facility in Alnwick, UK.

Huateng Pharma Develops A novel chemiluminescent Substrate APS-5

Industry, academia, and policy makers set to discuss the future of healthcare at Pharma Integrates 2022

Taking place on 17th November in London, Pharma Integrates is the must-attend event for leaders, strategists and innovators across pharma & healthcare looking to revolutionise modern medicine. An opportunity to make connections, discuss how to overcome market challenges and advance business goals.

Jumpcode Genomics Unveils an Expanded CRISPRclean® RNA Depletion Portfolio to Boost Discovery

Innovative new technologies empower medical and biopharma scientists and researchers to extract greater insights from the transcriptome.

Oncology Clinician-Scientist Jason Luke, MD Named physIQ Medical Advisor

– physIQ announced today that Jason Luke, MD, FACP, a recognized expert in immuno-oncology, professor of medicine, and clinical practitioner has been appointed to the company’s Medical Advisory Board. In this role, Dr. Luke will provide expert medical counsel for physIQ’s ongoing development of solutions to aide in oncology treatments, including physIQ’s development of digital biomarkers for inflammation.